This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Discipline | Molecular biosciences |
---|---|
Language | English |
Edited by | Michael Brunner |
Publication details | |
History | 1968–present |
Publisher | |
Frequency | 24/year |
After 12 months/Hybrid | |
4.124 (2020) | |
Standard abbreviations | |
ISO 4 | FEBS Lett. |
Indexing | |
CODEN | FEBLAL |
ISSN | 0014-5793 (print) 1873-3468 (web) |
LCCN | 68006508 |
OCLC no. | 1569056 |
Links | |
FEBS Letters is a not-for-profit peer-reviewed scientific journal published on behalf of the Federation of European Biochemical Societies (FEBS) by Wiley. It covers all aspects of molecular biosciences, including molecular biology and biochemistry. The aim of the journal is to publish primary research in the form of Research Articles, Research Letters, Communications and Hypotheses, as well as secondary research in the form of Review articles. The journal also publishes a News and Views column called "The Scientists' Forum". The editorial office of FEBS Letters is based in Heidelberg, Germany. The journal income is reinvested in science.
The initial idea of FEBS Letters as a journal for rapid communication of short reports in biochemistry, biophysics and molecular biology was proposed by the Secretary General of FEBS, W.J. Whelan, at the 4th FEBS Meeting held in Oslo in 1967. [1] [2] [3] After further discussions and preparations, the first issue of FEBS Letters appeared in July 1968 [4] with Satya Prakash Datta acting as Managing Editor. The initial editorial policy urged the authors to submit their manuscripts directly to a member of the editorial board, who independently evaluated them and, if needed, consulted external referees. [5] Apart from original research articles, early on FEBS Letters started publishing short reviews, hypotheses, discussion articles and meeting reports, as well as a number of supplements to regular issues extensively covering topical subjects. [3] In 2000 the handling of manuscripts was centralized and the editorial process amended and standardized. [6]
Satya Prakash Datta, who served as Managing Editor until 1985, was succeeded by Giorgio Semenza (1986-2000) and Matti Saraste (2000-2001). Between 2001 and 2021, the Managing Editor was Felix Wieland. [7] The current Editor in Chief is Michael Brunner.
The journal published 144 articles in 1968, and from then on steadily increased its output to reach an all-time high of 1733 published articles in 1999. [8]
FEBS Letters staff consists of the Editor in Chief, the Editorial Office and the editorial board. The editorial board is composed of Academic Editors, who are active scientists working in different fields of the molecular biosciences.
In accordance with the Editor in Chief, the staff at the Editorial Office evaluates all submissions based on editorial policy and general scientific criteria. Manuscripts that pass through the pre-screening process are distributed to appropriate Academic Editors. The Academic Editors evaluate the manuscripts, supervise the peer-review process and make final decisions autonomously. The handling time from submission to first decision is on average 2.3 weeks. [6] Manuscripts accepted for publication are processed by Wiley and published online, bundled in 24 issues per year.
FEBS Letters follows a typical scientific society publishing model, where the income generated by the journal is used by FEBS to fund its activities, i.e. FEBS fellowships, advanced courses and workshops, congresses, and travel grants. [9]
Special Issues are collections of topical Review articles written by distinguished scientists covering the latest developments on specific topics in the molecular biosciences. Special Issue articles are commissioned, but, nevertheless, undergo the usual evaluation procedure exerted by the journal. Every year a Special Issue is directly associated with the FEBS Congress and consists of a compilation of Review articles contributed by speakers presenting their work at the congress.
All accepted articles are published online by Wiley on behalf of FEBS. The FEBS Letters archive is completely digitalized and available back to the first issue in 1968. FEBS Letters follows a subscription-based model with a delayed and hybrid open access policy. All articles are made available to non-subscribers for free after 12 months, with Review articles being available for free immediately.
Every other year FEBS Letters offers a prestigious prize of €10,000 to the senior author of an outstanding Research Letter published in FEBS Letters during the previous two calendar years. The winning article is selected in an unbiased fashion by a special Award Committee formed by appointed members of the editorial board plus one external member. The awardee is invited to give a plenary lecture at the FEBS Congress, where she/he is presented with the award. [10] The award has been presented regularly since 2003. [10]
Year | Name | Affiliation |
---|---|---|
2020 | Tim Bartels | UK Dementia Research Institute at UCL, United Kingdom |
2018 | David Stuart | University of Oxford, United Kingdom |
2016 | Kim Nasmyth Jan Löwe | University of Oxford, United Kingdom MRC Laboratory of Molecular Biology, Cambridge, United Kingdom |
2014 | Susanna Törnroth-Horsefield | Lund University, Sweden |
2013 | Susumu Mitsutake | Hokkaido University, Sapporo, Japan |
2012 | Megumi Funakoshi-Tago | Keio University, Tokyo, Japan |
2011 | Shiro Suetsugu | University of Tokyo, Japan |
2010 | Hideo Iwai | University of Helsinki, Finland |
2009 | Frank Sargent | University of Dundee, United Kingdom |
2008 | Kaspar Locher | ETH Zurich, Switzerland |
2007 | Noboru Mizushima | Tokyo Medical and Dental University Graduate School, Japan |
2006 | Theresia Stradal | GBF, Braunschweig, Germany |
2005 | Elke Deuerling | ZBMH, Heidelberg, Germany |
2004 | Jie-Oh Lee | KAIST, Daejon, South Korea |
2003 | Kun Ping Lu | Harvard Medical School, Boston, United States |
The journal is indexed in:
Cancer Cell is a peer-reviewed scientific journal scientific journal that publishes articles that provide major advances in cancer research and oncology. The journal considers manuscripts that answer important questions relevant to naturally occurring cancers. Areas covered include basic cancer biology, therapeutic development, translational research, cancer model development, multi-omics and computational biology. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.
The International Union of Biochemistry and Molecular Biology (IUBMB) is an international non-governmental organisation concerned with biochemistry and molecular biology. Formed in 1955 as the International Union of Biochemistry (IUB), the union has presently 79 member countries and regions (as of 2020). The Union is devoted to promoting research and education in biochemistry and molecular biology throughout the world, and gives particular attention to localities where the subject is still in its early development.
The Journal of Biological Chemistry (JBC) is a weekly peer-reviewed scientific journal that was established in 1905. Since 1925, it is published by the American Society for Biochemistry and Molecular Biology. It covers research in areas of biochemistry and molecular biology. The editor is Alex Toker. As of January 2021, the journal is fully open access. In press articles are available free on its website immediately after acceptance.
Complement C1r subcomponent is a protein involved in the complement system of the innate immune system. In humans, C1r is encoded by the C1R gene.
Tissue kallikrein is an enzyme. This enzyme catalyses the following chemical reaction
Yuri Anatolievich Ovchinnikov was a Soviet bioorganic chemist. He was elected in 1970 as a full member of the USSR Academy of Sciences and subsequently became the youngest vice president of the academy in its history (1974-1988). He was elected to the American Philosophical Society in 1977. He was also president of the Federation of European Biochemical Societies (1984-1986), Director of the Institute of Bioorganic Chemistry in Moscow (1970-1988) and professor at Moscow State University. From 1972 through to 1984 he served concomitantly as head of the Laboratory of Protein Chemistry at the USSR Academy of Sciences' Institute of Protein.
Actin, alpha skeletal muscle is a protein that in humans is encoded by the ACTA1 gene.
Cathepsin L1 is a protein that in humans is encoded by the CTSL1 gene. The protein is a cysteine cathepsin, a lysosomal cysteine protease that plays a major role in intracellular protein catabolism.
Potassium voltage-gated channel, shaker-related subfamily, member 5, also known as KCNA5 or Kv1.5, is a protein that in humans is encoded by the KCNA5 gene.
Neuroendocrine protein 7B2 is a protein that in humans is encoded by the SCG5 gene. The protein expressed by this gene is widely distributed in neuroendocrine tissues. It functions as a chaperone protein for the proprotein convertase PC2 by blocking the aggregation of this protein, and is required for the production of an active PC2 enzyme. It is an intrinsically disordered protein that may also function as a chaperone for other aggregating secretory proteins in addition to proPC2. 7B2 has been identified in vertebrates and in invertebrates as low as flatworms and insects. It is also called Sgne1 and Secretogranin V. In C. elegans, it was originally called e7B2 and then renamed Seven B Two. There is a Pfam entry for this protein: Secretogranin_V (PF05281).
Rnd1 is a small signaling G protein, and is a member of the Rnd subgroup of the Rho family of GTPases. It is encoded by the gene RND1.
Eukaryotic translation initiation factor 4E type 2 is a protein that in humans is encoded by the EIF4E2 gene. It belongs to the eukaryotic translation initiation factor 4E family.
Guanine nucleotide-binding protein subunit alpha-13 is a protein that in humans is encoded by the GNA13 gene.
Annual Review of Biochemistry is an annual peer-reviewed scientific journal published by Annual Reviews, a nonprofit scientific publisher. Its first volume was published in 1932, and its founding editor was J. Murray Luck. The current editor is Roger D. Kornberg. The journal focuses on molecular biology and biological chemistry review articles. As of 2023, Journal Citation Reports gives the journal an impact factor of 16.6, ranking it seventh out of 285 journals in the category "Biochemistry and Molecular Biology". As of 2023, it is being published as open access, under the Subscribe to Open model.
Ecadotril is a neutral endopeptidase inhibitor ((NEP) EC 3.4.24.11) and determined by the presence of peptidase family M13 as a neutral endopeptidase inhibited by phosphoramidon. Ecadotril is the (S)-enantiomer of racecadotril. NEP-like enzymes include the endothelin-converting enzymes. The peptidase M13 family believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides, neprilysin is another member of this group, in the case of the metallopeptidases and aspartic, the nucleophiles clan or family for example MA, is an activated water molecule. The peptidase domain for members of this family also contains a bacterial member and resembles that of thermolysin the predicted active site residues for members of this family and thermolysin occur in the motif HEXXH. Thermolysin complexed with the inhibitor (S)-thiorphan are isomeric thiol-containing inhibitors of endopeptidase EC 24-11 (also called "enkephalinase").
Momordin or α-momorcharin is one of several related proteins isolated from several plants of the genus Momordica, which includes the bitter melon and the balsam apple.
Geraniol 8-hydroxylase (EC 1.14.14.83, Formerly EC 1.14.13.152, CYP76B6, G10H, CrG10H, SmG10H) is an enzyme with systematic name geraniol,NADPH:oxygen oxidoreductase (8-hydroxylating). This enzyme catalyses the following chemical reaction
Avadhesha Surolia is a glycobiologist at the Indian Institute of Science (IISc), Bangalore. He was born in Kishangarh, Rajasthan, India. Presently, he is an honorary professor at the Molecular Biophysics Unit, IISc and holds the Bhatnagar fellowship of the Council of Scientific and Industrial Research (CSIR). He is known for his work on lectin structure and interactions, orientation and dynamics of cell surface carbohydrate receptors and protein folding, diabetes, antimalarials and anti-cancer agents based on curcumin, flavonoids, etc. In addition, neuropathic pain, neurodegenerative disorders and the link between immunity and obsessive–compulsive disorder are areas of his current interest
William Joseph Whelan FRS was a British-born American biochemist. He was professor and chair of biochemistry and molecular biology at the Leonard M. Miller School of Medicine of the University of Miami. He founded the annual Miami Winter Symposium in 1967 and was chief editor of the journal IUBMB Life.
Athel Cornish-Bowden is a British biochemist known for his numerous textbooks, particularly those on enzyme kinetics and his work on metabolic control analysis.
{{cite journal}}
: Cite journal requires |journal=
(help)